In a significant development for organ transplantation, two U.S. biotechnology companies, United Therapeutics and ...

Learn more about whether Catalyst Pharmaceuticals, Inc. or Ionis Pharmaceuticals, Inc. is a better investment based on AAII's ...

Tectonic Therapeutic has done well to advance its Fc-fusion protein candidate TX45 into a phase 2 study targeting patients ...

UBS lowered the firm’s price target on United Therapeutics (UTHR) to $460 from $475 and keeps a Buy rating on the shares. United Therapeutics ...

Michael Benkowitz, President and COO of United Therapeutics Corp (NASDAQ:UTHR), recently executed a series of stock transactions, according to a recent SEC filing. On February 3, Benkowitz sold shares ...

The U.S. Food and Drug Administration has approved the first-ever clinical trials testing pig kidney transplants in people ...

History of the LGBTQI+ Workplace . In the 1950s, gay and lesbian employees were removed from federal government and intelligence jobs during the Lavender Scare. In 1953, President ...

Two US biotech companies say the Food and Drug Administration has cleared them to conduct clinical trials of their ...

The U.S. Food and Drug Administration (FDA) has approved the first-ever clinical trials testing pig kidney transplants ...

Silver Spring’s United Therapeutics has scored a regulatory green light to start clinical trials for its genetically modified pig kidneys to be transplanted into humans. It's as significant for the ...

United Therapeutics (UTHR) announced full enrollment of the TETON 1 study evaluating the use of Tyvaso or treprostinil, inhalation solution or ...

The first clinical trials using organs from genetically modified pigs offer hope to patients with kidney failure, who face a ...